Published in Thromb Haemost on February 19, 2010
Antimicrobial-sensing proteins in obesity and type 2 diabetes: the buffering efficiency hypothesis. Diabetes Care (2011) 0.81
Cardiovascular abnormalities in hyperthyroidism: a prospective Doppler echocardiographic study. Am J Med (2005) 2.90
Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet (2011) 2.73
Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab (2013) 2.64
Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature (2011) 2.59
Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev (2003) 2.58
Cross-talk between iron metabolism and diabetes. Diabetes (2002) 2.36
Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects. Diabetes Care (2007) 2.05
Adipose tissue μ-crystallin is a thyroid hormone-binding protein associated with systemic insulin sensitivity. J Clin Endocrinol Metab (2014) 1.96
Targeting the circulating microRNA signature of obesity. Clin Chem (2013) 1.95
MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS One (2010) 1.89
Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes Care (2014) 1.86
The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab (2008) 1.85
Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. Diabetes (2002) 1.81
Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr (2005) 1.66
Changes in circulating microRNAs are associated with childhood obesity. J Clin Endocrinol Metab (2013) 1.61
Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI. Arch Dermatol Res (2012) 1.48
Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care (2003) 1.45
Low serum mannose-binding lectin as a risk factor for new onset diabetes mellitus after renal transplantation. Transplantation (2009) 1.44
Microscopic examination of intracellular organisms in protected bronchoalveolar mini-lavage fluid for the diagnosis of ventilator-associated pneumonia. Chest (2003) 1.42
[Factors influencing incipient diabetic nephropathy: ESODIAH study]. Med Clin (Barc) (2005) 1.38
The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet (2003) 1.31
PP2A regulatory subunit PP2A-B' counteracts S6K phosphorylation. Cell Metab (2010) 1.29
Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. Diabetes (2006) 1.24
Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine (2010) 1.24
Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One (2012) 1.23
Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care (2009) 1.19
Complement factor H is expressed in adipose tissue in association with insulin resistance. Diabetes (2009) 1.19
Serum visfatin increases with progressive beta-cell deterioration. Diabetes (2006) 1.19
IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies. Diabetes (2006) 1.18
Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care (2006) 1.17
Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and β cell function in elderly men at high cardiovascular risk. Am J Clin Nutr (2011) 1.17
Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab (2006) 1.16
CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. J Clin Endocrinol Metab (2003) 1.15
Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss. J Clin Endocrinol Metab (2010) 1.14
Circulating omentin concentration increases after weight loss. Nutr Metab (Lond) (2010) 1.13
The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity (Silver Spring) (2009) 1.12
CD14 modulates inflammation-driven insulin resistance. Diabetes (2011) 1.11
Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity (Silver Spring) (2011) 1.11
Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study. J Clin Endocrinol Metab (2002) 1.08
Iron stores, blood donation, and insulin sensitivity and secretion. Clin Chem (2005) 1.07
Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance? Curr Opin Clin Nutr Metab Care (2011) 1.07
Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome. J Clin Endocrinol Metab (2009) 1.06
Salicylates increase insulin secretion in healthy obese subjects. J Clin Endocrinol Metab (2008) 1.06
Differential proteomics of omental and subcutaneous adipose tissue reflects their unalike biochemical and metabolic properties. J Proteome Res (2009) 1.06
Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. J Clin Endocrinol Metab (2006) 1.05
Extracellular fatty acid synthase: a possible surrogate biomarker of insulin resistance. Diabetes (2010) 1.02
Obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels. BMC Physiol (2012) 1.02
A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia (2013) 1.00
Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2. Int Immunol (2004) 1.00
Maternal and cord blood adiponectin multimeric forms in gestational diabetes mellitus: a prospective analysis. Diabetes Care (2011) 1.00
Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrinol Metab (2003) 0.99
A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis (2003) 0.99
OCT1 Expression in adipocytes could contribute to increased metformin action in obese subjects. Diabetes (2010) 0.98
Adiponectin is associated with vascular function independent of insulin sensitivity. Diabetes Care (2004) 0.97
Serum interleukin-6 correlates with endothelial dysfunction in healthy men independently of insulin sensitivity. Diabetes Care (2007) 0.97
Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity. Diabetes Care (2002) 0.96
The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity. Diabetes (2011) 0.96
Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome. Clin Endocrinol (Oxf) (2006) 0.96
A nontargeted proteomic approach to the study of visceral and subcutaneous adipose tissue in human obesity. Mol Cell Endocrinol (2012) 0.96
Arterial stiffness is increased in patients with type 1 diabetes without cardiovascular disease: a potential role of low-grade inflammation. Diabetes Care (2012) 0.96
Serum levels of TWEAK and scavenger receptor CD163 in type 1 diabetes mellitus: relationship with cardiovascular risk factors. a case-control study. PLoS One (2012) 0.95
Increased levels of calprotectin in obesity are related to macrophage content: impact on inflammation and effect of weight loss. Mol Med (2011) 0.94
Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25). Diabetes (2006) 0.94
Structural damage in diabetic nephropathy is associated with TNF-α system activity. Acta Diabetol (2011) 0.94
Grape-seed procyanidins modulate inflammation on human differentiated adipocytes in vitro. Cytokine (2009) 0.93
Serum and urinary concentrations of calprotectin as markers of insulin resistance and type 2 diabetes. Eur J Endocrinol (2012) 0.93